Alerts & notifications
-
2C-B misrepresented as MDMA in DunedinNotification|21 June 2024
2C-B has been detected in a pinkish/purple powder presumed to be MDMA in the Dunedin area
-
Ketamine analogue sold as ketamine in the Wellington regionNotification|07 June 2024
The ketamine analogue 2-Fluoro-2-Oxo-PCE was found in two samples of white powder/crystal sold as ketamine in the Wellington region.
-
Highly potent synthetic opioid detected in fake diazepam tabletNotification|06 May 2024
UPDATED 6 May 2024
A highly potent synthetic opioid, N-Desethyletonitazene, has been detected in a fake benzodiazepine tablets. -
Synthetic Cannabinoid misrepresented as DMTNotification|03 May 2024
UPDATED 3 May 2024
Synthetic Cannabinoid MDMB-4en-PINACA has been detected in a yellow powder presumed to be DMT -
Heroin sold as ketamine in Auckland regionNotification|25 November 2023
Heroin has been found in a white powder that was sold as ketamine in the Auckland region.
-
Misrepresented MDMA linked to serious harm in Hawke’s BayNotification|08 August 2023
UPDATED 11 August 2023
Serious harm has been linked with misrepresented MDMA in the Hawke’s Bay area. -
Potent stimulant Alpha-PVP misrepresented as MDMANotification|06 April 2023
An off-white powder being sold as MDMA in Auckland has been found to contain Alpha-PVP.
-
Fentanyl in white powder causes multiple hospitalisations in Wairarapa regionAlert|25 June 2022
UPDATED 1 JULY 2022
Fentanyl found in white powder linked to serious harm events in the Wairarapa region. -
Misrepresented MDMA linked to serious harm in Whanganui areaNotification|05 June 2022
An unknown brown powder being sold as MDMA has been linked to serious harm events in the Whanganui area.
-
Potential adulteration of GBL in AucklandNotification|14 April 2022
We've identified harm linked to the potential adulteration of GBL and GBL-type substances in Auckland.